Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1%. Glenmark's Clindamycin ...
Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a product that is bioequivalent and therapeutically ...
Glenmark Pharma ceuticals Inc., USA introduces clindamycin phosphate foam, 1%: Our Bureau, Mumbai Wednesday, February 12, 2025, 12:30 Hrs [IST] Glenmark Pharmaceuticals Inc., USA ...
Have you ever used one of the best foam rollers? If so, you’ve probably used one in physical therapy or with a personal ...
From price, design and comfort, we explore the key differences between the DreamCloud Luxury Hybrid and the Helix Midnight ...
Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, today announced the launch of Essentiatm, a versatile, multi-acuity bed frame designed to ...
Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...